Identifying Those Patients with Type 2 Diabetes Who Might Benefit from Insulin Pump Therapy: Literature Review, Clinical Opportunities, Potential Benefits & Challenges.

Global prevalence and increasing incidence rates of type 2 diabetes (T2D) has rippling effects on healthcare costs and diminishing quality of life. Despite advances in technology, continuous subcutaneous insulin infusions (CSII), or insulin pump therapy, is rarely being recommended by health care professionals (HCP) and is underutilized in T2D management. This review analyzes the available literature for CSII use in T2D patients. Moreover, it discusses which groups of patients may benefit from CSII, potential challenges to CSII use, and suggests future directions for research to expand the applicability of this technology to the broader T2D population. This article is protected by copyright. All rights reserved.